NCT02221830View on ClinicalTrials.gov

Postpartum Hemorrhage Prevention in Patients With Preeclampsia (PHP3 Study)

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

July 17, 2019

Study Completion Date

July 17, 2019

Conditions
Preeclampsia
Interventions
DRUG

Oxytocin

Our intervention simply replaces the standardly given normal saline with treatment (normal saline + oxytocin)

DRUG

Placebo

This intervention utilizes a Placebo Camparator

Trial Locations (1)

80045

University of Colorado Clinical and Translational Research Center, Aurora

All Listed Sponsors
lead

University of Colorado, Denver

OTHER

NCT02221830 - Postpartum Hemorrhage Prevention in Patients With Preeclampsia (PHP3 Study) | Biotech Hunter | Biotech Hunter